Graphene is the much lauded and hyped wonder material set to enable the next generation of advanced technologies and the Stirling based outfit, Integrated Graphene are set to launch their first graphene-enhanced product. The launch of their flagship 3D Graphene Foam electrodes, coincides with the company's rebranding to signal their transition to commercialise their revolutionary 3D Graphene process in their first product, Gii-Sens. The rebrand also benchmarks the transition from an R&D company to Advanced Materials Manufacturer.
Integrated Graphene (formerly known as RD Graphene) are taking their hyper-sensitive 3D Graphene Foam electrodes to the Human Diagnostics market to enable biosensors with the performance to bring laboratory tests to the point of need, enabling rapid testing. As a spin out from their R&D origins, they are able to leverage their experience of working with diagnostics manufacturers with a full suite of assay and device development services. Thanks to their novel manufacturing process, Integrated Graphene are ideally positioned to fulfil the graphene promise across markets with a product finally ready to meet the industry demands, meaning the possibilities are endless. For further information see the IDTechEx report on Graphene, 2D Materials and Carbon Nanotubes: Markets, Technologies and Opportunities 2019-2029.
Today, they hope that this flagship graphene product, launched in conjunction with their new Integrated Graphene brand, will mark the first steps on an ambitious commercial journey that will see them establish themselves as the world's leading producer of pure 3D Graphene Foam. The company's co-founders Claus Marquordt and Marco Caffio believe they are primed to capitalise on huge desire for a market ready application of graphene to enable the next generation of technologies. Speaking about the launch of Gii-Sens, the former had the following comments -
"Up until now we have been operating in the research field of academia, tentatively foraging through to commercial partnerships whilst we refined our proposition. But as of today, we are launching a limited supply of our electrodes to the market, to ensure a more tailored experience as we offer exclusive access to our customer services team, ensuring customers get the best experience of using Gii-Sens. A full-scale commercial launch is scheduled for early 2021. Most graphene solutions on the market presently aren't truly graphene, they are a derivative - but our Gii-Sens electrodes are manufactured from pure 3D Graphene Foam, making them the most pristine form of graphene commercially available on the market today."
With so many market applications, it would be easy to get lost in a sea of opportunity, but Integrated Graphene is focusing on sensing and biosensing solutions with their first foray into the market. Advances in manufacturing processes and device integration are propelling developments in biosensors; and according to Frost & Sullivan analysis, the global biosensor market is expected to grow at a 12% compound annual growth rate (CAGR) during 2018 -2023, from revenues of $17.7 billion in 2018, to reach $31.2 billion by the end of 2023.
Dr Marco Caffio said the following on the potential for growth for the organisation - "For several years now, people have been chasing the perfect single layer, but 2D graphene offers only a limited surface area and is currently restricted to small-scale production. Because our 3D Graphene Foam can be grown directly on to any substrate, at scale, it opens many more possibilities for using graphene. Areas, where we have recently noticed a particularly high interest in our 3D Graphene Foam, include sensing technologies and energy systems, but almost any industry could take its products to the next level by incorporating graphene. Taking this first product to market will pave the way for other applications to follow when our partners start to see significant improvements in performance graphene enables."
The company is hotly tipped to continue its promising ascension after a successful start to life which has seen it win over 30 grant funding awards for the wide breadth of applications. As well as biosensing solutions, Integrated Graphene has also identified supercapacitors as their next target market, which is another lucrative and topical avenue that presents a significant opportunity for further growth going forward. The company will continue to develop their wide-ranging potential for their pure 3D Graphene Foam for new markets and technologies, and there is sure to be no shortage of suitors looking to exploit the benefits of graphene-enhanced technology.
Integrated Graphene in brief
Scotland based Integrated Graphene is an advanced material supplier who has invented, patented and commercialised a revolutionary design for manufacture process to produce high performing pure 3D Graphene Foam, Gii, on any surface, in seconds. Integrated Graphene tailors and enhances Gii for specific applications to enable disruptive manufacturers across industries to access pure 3D Graphene Foam and develop products of the future, today, within each market. Human diagnostics is our beachhead market, partnering with life science organisations to create novel lab-on-a-chip assays for the point of need, utilising Integrated Graphene's proprietary Gii-Sens material innovation and in-house concept to commercialisation microfluidic IVD development services. Integrated Graphene is using the Gii process to produce the world's first pure graphene supercapacitor, Gii-Cap, to enable fast charging and smart power for product innovators to fulfil global green electrification agendas across limitless applications. Integrated Graphene invite you to engage with us to join the technology breakthrough of the decade.
To discover more, please visit www.integratedgraphene.com .
For further information, images and editorial/support, please contact
Sean Lightheart, Marketing Manager:
www.integratedgraphene.com Linkedin Integrated Graphene
Source: Integrated Graphene